It has been observed that the loss of TLR4 function results in blunted microglial activation and increased amyloid pathology in 9-month APP/PS1 mice [150, 151], whilst younger (5-month) mice showed impaired microglial activation but no change in Aβ deposition [151]. This evidence concerns the gene APP and amyloidosis.